trial

Linguistic Predictors of Outcomes in Psychosis

NCTId NCT05601050
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 77 (actual)
Sponsored by Northwell Health, Early Treatment Program at Lenox Hill
Primary completion 2023-03-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
77 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2021-03-04
Primary completion
2023-03-01
Eligibility
ALL · 15 Years · 40 Years

Interventions & indications

Drugs
—

Sponsors

Northwell Health, Early Treatment Program at Lenox HillLead Sponsor
Winterlight LabsCollaborator

Investigators

1
Sunny X Tang, MDPrincipal Investigator

Sites

1 total
Glen Oaks, United States

Facts & assertions

4 sourced
Enrollment
77
Phase
NA
Primary Completion Date
2023-03-01
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Northwell Health, Early Treatment Program at Lenox Hill
company
collaborator
Winterlight Labs
company
indication
Schizophrenia and Related Disorders
indication
Schizophrenia
indication
Speech
indication
investigator
Sunny X Tang, MD
person